Internal Medicine, Gastroenterology · Lexington, KY
NPI
1811974298
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3225 Summit Square Pl Ste 100
Lexington, KY, 40509
Phone (859) 266-7999
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
497 services
Medicare patients, 2024
320
Average age 73
Drug cost, 2024
$1.9M
1,496 prescriptions
Company payments, 2025
$1,058
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Earl G Robbins II was code 45385 (colonoscopy - lesion removal), 106 times for 106 patients. In total Earl G Robbins II billed 497 services in 33 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 106 | 106 | $191.27 | $20K |
| 99214 Office E&M - Established | Office | 79 | 65 | $73.12 | $5,777 |
| 43239 Upper GI Endoscopy | Facility | 76 | 75 | $39.54 | $3,005 |
| 43249 Upper GI Endoscopy | Facility | 41 | 41 | $97.96 | $4,016 |
| 99204 Office E&M - New | Office | 32 | 32 | $117.07 | $3,746 |
| 45380 Lower GI Endoscopy - Other | Facility | 29 | 29 | $80.98 | $2,348 |
| 99203 Office E&M - New | Office | 18 | 18 | $76.78 | $1,382 |
| 99213 Office E&M - Established | Office | 16 | 16 | $47.77 | $764 |
By year: 2022 $81K for 725 services; 2023 $81K for 845 services; 2024 $51K for 497 services.
Medicare prescription drug claims, 2024
In 2024, the drug Earl G Robbins II prescribed most often to Medicare patients was Omeprazole, with 184 prescriptions and refills. In total Earl G Robbins II wrote 1,496 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 184 | 399 | 52 | $1,423 |
| Buspirone Hcl Generic | 161 | 249 | 43 | $1,112 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 135 | 135 | 132 | $8,777 |
| Creon Lipase/Protease/Amylase | 106 | 141 | 39 | $200K |
| Lorazepam Generic | 51 | 51 | Under 11 | $331 |
| Ursodiol Generic | 50 | 73 | 11 | $16K |
| Budesonide Dr Budesonide | 46 | 60 | 13 | $7,578 |
| Movantik Naloxegol Oxalate | 41 | 51 | Under 11 | $20K |
| Sucraid Sacrosidase | 36 | 36 | 14 | $495K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 31 | 31 | 31 | $445 |
| Colestipol Hcl Generic | 30 | 48 | 13 | $1,764 |
| Motegrity Prucalopride Succinate | 27 | 39 | Under 11 | $17K |
| Ocaliva Obeticholic Acid | 27 | 27 | Under 11 | $252K |
| Stelara Ustekinumab | 25 | 43 | Under 11 | $708K |
| Alosetron Hcl Generic | 24 | 28 | Under 11 | $14K |
Brand drugs: 522 claims; generic drugs: 974 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Earl G Robbins II $1,058 ($1,058 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $356.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $356 |
| Janssen Biotech, Inc. JNJ | 9 | $142 |
| Phathom Pharmaceuticals, Inc. PHAT | 13 | $129 |
| Pfizer Inc. PFE | 3 | $102 |
| Gilead Sciences, Inc. GILD | 2 | $45.81 |
| Ardelyx, Inc. ARDX | 2 | $37.26 |
| Intercept Pharmaceuticals, Inc. | 2 | $36.4 |
| Aimmune Therapeutics, Inc. | 2 | $32.71 |
| QOL Medical, LLC | 2 | $32.59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $24.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.